Credit Suisse Ag Arrowhead Pharmaceuticals, Inc. Transaction History

Credit Suisse Ag

$101 Billion
Q1 2024

A detailed history of Credit Suisse Ag transactions in Arrowhead Pharmaceuticals, Inc. stock. As of the latest transaction made, Credit Suisse Ag holds 1,626,513 shares of ARWR stock, worth $31.5 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

1,626,513

Previous 1,745,342 6.81%

Holding current value

$31.5 Million

Previous $53.4 Million 12.9%

% of portfolio

0.05%

Previous 0.05%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	SELL	$27.21 - $39.48 $3.23 Million - $4.69 Million	-118,829 Reduced 6.81%	1,626,513 $46.5 Million
Q4 2023 Feb 08, 2024	BUY	$21.2 - $31.03 $4.59 Million - $6.72 Million	216,664 Added 14.17%	1,745,342 $53.4 Million
Q3 2023 Nov 13, 2023	BUY	$26.2 - $36.08 $2.57 Million - $3.54 Million	98,111 Added 6.86%	1,528,678 $41.1 Million
Q2 2023 Aug 11, 2023	BUY	$25.16 - $41.38 $1.09 Million - $1.8 Million	43,481 Added 3.13%	1,430,567 $51 Million
Q1 2023 May 10, 2023	BUY	$23.68 - $38.51 $1.15 Million - $1.87 Million	48,570 Added 3.63%	1,387,086 $35.2 Million
Q4 2022 Feb 13, 2023	BUY	$28.0 - $40.56 $1.56 Million - $2.26 Million	55,651 Added 4.34%	1,338,516 $54.3 Million
Q3 2022 Nov 10, 2022	SELL	$29.63 - $48.31 $6,074 - $9,903	-205 Reduced 0.02%	1,282,865 $42.4 Million
Q2 2022 Aug 12, 2022	BUY	$27.79 - $50.61 $208,814 - $380,283	7,514 Added 0.59%	1,283,070 $45.2 Million
Q1 2022 May 16, 2022	BUY	$39.62 - $69.97 $498,974 - $881,202	12,594 Added 1.0%	1,275,556 $58.7 Million
Q4 2021 Feb 14, 2022	SELL	$58.09 - $82.51 $10.8 Million - $15.3 Million	-185,552 Reduced 12.81%	1,262,962 $83.7 Million
Q3 2021 Nov 12, 2021	BUY	$58.38 - $84.96 $3.29 Million - $4.78 Million	56,320 Added 4.05%	1,448,514 $90.4 Million
Q2 2021 Aug 16, 2021	SELL	$62.15 - $90.32 $6.06 Million - $8.81 Million	-97,522 Reduced 6.55%	1,392,194 $115 Million
Q1 2021 May 14, 2021	SELL	$61.35 - $90.47 $1.49 Million - $2.19 Million	-24,231 Reduced 1.6%	1,489,716 $98.8 Million
Q4 2020 Feb 12, 2021	BUY	$43.82 - $85.37 $2.13 Million - $4.16 Million	48,705 Added 3.32%	1,513,947 $116 Million
Q3 2020 Nov 13, 2020	BUY	$33.21 - $51.27 $3.2 Million - $4.95 Million	96,475 Added 7.05%	1,465,242 $63.1 Million
Q2 2020 Aug 12, 2020	BUY	$26.12 - $43.27 $14.6 Million - $24.1 Million	557,875 Added 68.8%	1,368,767 $59.1 Million
Q1 2020 May 13, 2020	BUY	$20.56 - $63.12 $8.83 Million - $27.1 Million	429,668 Added 112.71%	810,892 $23.3 Million
Q4 2019 Feb 12, 2020	BUY	$28.14 - $73.01 $7.82 Million - $20.3 Million	277,732 Added 268.36%	381,224 $24.2 Million
Q3 2019 Nov 12, 2019	BUY	$26.26 - $34.86 $532,001 - $706,228	20,259 Added 24.34%	103,492 $2.92 Million
Q2 2019 Aug 14, 2019	SELL	$17.43 - $28.82 $3.77 Million - $6.23 Million	-216,032 Reduced 72.19%	83,233 $2.21 Million
Q1 2019 May 14, 2019	SELL	$12.05 - $20.18 $541,020 - $906,041	-44,898 Reduced 13.05%	299,265 $5.49 Million
Q4 2018 Feb 13, 2019	BUY	$10.74 - $19.7 $2.81 Million - $5.15 Million	261,424 Added 315.96%	344,163 $4.28 Million
Q3 2018 Nov 13, 2018	BUY	$14.0 - $20.3 $151,802 - $220,112	10,843 Added 15.08%	82,739 $1.59 Million
Q2 2018 Aug 14, 2018	BUY	$6.37 - $14.02 $457,977 - $1.01 Million	71,896 New	71,896 $978,000
Q1 2018 May 15, 2018	SELL	$3.72 - $7.64 $135,739 - $278,775	-36,489 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$3.14 - $4.5 $114,575 - $164,200	36,489	36,489 $134,000

Others Institutions Holding ARWR

# of Institutions

295

Shares Held

92.3M

Call Options Held

1.33M

Put Options Held

549K

View Full List

About ARROWHEAD PHARMACEUTICALS, INC.

Ticker ARWR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,849,000
Market Cap $2.05B
Description
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...

More about ARWR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

News

Stay updated on Credit Suisse Ag with notifications on news.

Account